Stamford, CT -- (SBWIRE) -- 09/19/2013 -- High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis. Our Penny Stock Newsletter will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service. Today’s stocks to watch are: Golden Star Resources Ltd. (USA)(NYSEMKT:GSS), Catalyst Pharmaceutical Partners, Inc.(NASDAQ:CPRX), Galena Biopharma Inc(NASDAQ:GALE), Noranda Aluminum Holding Corporation(NYSE:NOR)
Golden Star Resources Ltd. (USA)(NYSEMKT:GSS) fell 6.43% to $0.506. Golden Star Resources Ltd, (Golden Star) is an international gold mining and exploration company producing gold in Ghana, West Africa. The Company also conducts gold exploration in other countries in West Africa and in South America. Golden Star owns controlling interests in several gold properties in southwest Ghana. Through a 90% owned subsidiary, Golden Star (Bogoso/Prestea) Limited (GSBPL), it owns and operates the Bogoso/Prestea gold mining and processing operations (Bogoso/Prestea) located near the town of Bogoso, Ghana.
Is GSS A Strong At The CMP? Get Advantage Of Our Free Trend Analysis Here
Catalyst Pharmaceutical Partners, Inc.(NASDAQ:CPRX) added 5.95% to $2.85. Catalyst Pharmaceutical Partners, Inc. is a development-stage biopharmaceutical company. The Company is focused on the development and commercialization of prescription drugs targeting addiction diseases and disorders of the central nervous system with a focus on the treatment of addiction and epilepsy. As of December 31, 2011, the Company had two drugs in development: CPP-109 and CPP-115. of December 31, 2011, it was evaluating its drug candidate, CPP-109 for the treatment of cocaine addiction.
Is CPRX A Good Buy After The Recent Price Movement? Find Out Here
Galena Biopharma Inc(NASDAQ:GALE) increased 0.76 to $1.98. Galena Biopharma, Inc. (Galena), formerly RXi Pharmaceuticals Corporation, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using targeted biotherapeutics. The Company is pursuing the development of cancer therapeutics using peptide-based immunotherapy products, including its main product candidate, NeuVaxTM (E75), for the treatment of breast cancer and other tumors.
Should Investors Rush To Buy GALE After The Solid Rally? Get Special Report Here
Noranda Aluminum Holding Corporation(NYSE:NOR) added 0.75% to $2.69. Noranda Aluminum Holding Corporation (Noranda HoldCo) is a North American integrated producer of aluminum products and rolled aluminum coils. The Company has two businesses: the Company's upstream business and downstream business. The Company's upstream business consists of three reportable segments: primary aluminum, alumina, and bauxite.
Can Traders Buy NOR After The Solid Rally? Get Free Trend Analysis Here
High Rising Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to.We will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)